USA Spinal Surgery Devices Market

USA Spinal Surgery Devices Market Analysis

The USA Spinal Surgery Devices Market is expected to register a CAGR of 7.5% during the forecast period.

USA Spinal Surgery Devices Market Trends

Cervical Fusion is Expected to Show a Healthy Growth During the Forecast Period

Cervical fusion is a surgery that fuses selected bones in the cervical spine. It is also known as arthrodesis. Cervical spine fusion can be performed in many ways. The bone used for fusion can be taken from a bone bank or can be obtained from the patient’s own body. The bone is used to make a bridge between adjacent vertebrae. The presence of product approval is expected to drive the demand in this segment. For instance, in 2019, Spinal Kinetics LLC received the US FDA (Food and Drug Administration) approval for its product M6-C Artificial Cervical Disc. It is an implant that is used for replacing the damaged or diseased disc in the spine, C3-C7. Thus, considering all the above-mentioned factors associated with cervical fusion surgery, the market is expected to propel over the forecast period.​

However, the outcome of the surgery is still questionable. Alternative treatments such as C-ADR which have been observed to provide better efficacy and are cost-effective is expected to act as a major restraint impeding the growth of cervical fusion in the market.

USA Spinal Surgery Devices Industry Overview

Some of the major players in the USA Spinal Surgery Devices market are Zimmer Biomet Holdings, Inc, Stryker Corporation, Medtronic Plc, Johnson & Johnson, Globus Medical Inc., B.Braun Melsungen AG(Aesculap Implant System, LLC), Joimax GmbH, Bioventus LLC.

USA Spinal Surgery Devices Market Leaders